![]() |
|
|
Vol. 280, Issue 3, 1471-1479, 1997
Pharmaceutical Research Laboratories I, Pharmaceutical Research
Division, Takeda Chemical Industries, Ltd., Osaka, Japan
To identify the chemical mediators involved in the pathogenesis of
allergic rhinitis, we studied the effects of the thromboxane (TX)
A2 receptor antagonist seratrodast, the peptide leukotriene receptor antagonist pranlukast and the antihistamine azelastine using a
guinea pig model of allergic rhinitis. In guinea pigs actively
sensitized by aerosol inhalation of antigen, antigen challenge into the
nasal cavity increased both the nasal vascular permeability and the
intranasal pressure; it also induced swelling of the nasal mucosa,
which was evaluated by magnetic resonance imaging. Both seratrodast and
azelastine significantly inhibited these antigen-induced responses when
the drugs were administered p.o. 1 hr before antigen challenge. Also,
the TX synthetase inhibitor ozagrel reduced the antigen-induced
increase in nasal vascular permeability. On the other hand, pranlukast
had little effect on the antigen-induced increases in nasal vascular
permeability and intranasal pressure. Perfusions and inhalations of
U-46619, a stable TXA2 mimetic, or of histamine into the
nasal cavity caused concentration-dependent increases in nasal vascular
permeability and intranasal pressure in normal guinea pigs. Leukotriene
C4 also induced these responses, but the maximal responses
to leukotriene C4 were less than the maximal responses to
U-46619 or histamine. On the other hand, these responses were not
induced by prostaglandin D2 or prostaglandin
F2
. Moreover, the U-46619- and histamine-induced increases in vascular permeability and intranasal pressure were significantly inhibited by seratrodast and azelastine, respectively. In
addition, levels of TXB2, a stable breakdown product of
TXA2, and histamine in nasal lavage fluid increased after
antigen challenge in actively sensitized guinea pigs. These results
suggest that TXA2 and histamine play important roles in the
pathogenesis of experimental allergic rhinitis in guinea pigs.
This article has been cited by other articles:
![]() |
E. Bohm, G. J. Sturm, I. Weiglhofer, H. Sandig, M. Shichijo, A. McNamee, J. E. Pease, M. Kollroser, B. A. Peskar, and A. Heinemann 11-Dehydro-thromboxane B2, a Stable Thromboxane Metabolite, Is a Full Agonist of Chemoattractant Receptor-homologous Molecule Expressed on TH2 Cells (CRTH2) in Human Eosinophils and Basophils J. Biol. Chem., February 27, 2004; 279(9): 7663 - 7670. [Abstract] [Full Text] [PDF] |
||||